Vaccine Efficacy Calculator

What is Vaccine Efficacy (VE)?

Vaccine efficacy (VE) measures the proportionate reduction in disease attack rate between vaccinated and unvaccinated cohorts under optimal, controlled clinical trial conditions (such as double-blind, randomized controlled trials). In epidemiological research, vaccine efficacy determines the direct biological protection a vaccine candidate provides against symptomatic illness, laboratory-confirmed infection, hospitalization, or mortality.

Vaccine Efficacy and Relative Risk Formulas

Vaccine efficacy is calculated from the attack rate (incidence rate) among the vaccinated cohort ($\text{AR}_v$) and the unvaccinated control cohort ($\text{AR}_u$):

$$\text{AR}_v = \frac{a}{N_v}, \quad \text{AR}_u = \frac{c}{N_u}$$

Where $a$ is the number of confirmed disease cases in the vaccinated cohort of size $N_v$, and $c$ is the number of confirmed cases in the placebo or unvaccinated cohort of size $N_u$.

The Relative Risk (or Risk Ratio, $\text{RR}$) is:

$$\text{RR} = \frac{\text{AR}_v}{\text{AR}_u} = \frac{a / N_v}{c / N_u}$$

The Vaccine Efficacy ($\text{VE}$) percentage is therefore:

$$\text{VE (\%)} = \left(\frac{\text{AR}_u - \text{AR}_v}{\text{AR}_u}\right) \times 100\% = (1 - \text{RR}) \times 100\%$$

Absolute Risk Reduction (ARR) and Number Needed to Vaccinate (NNV)

While vaccine efficacy illustrates relative protection, public health decision-makers also evaluate absolute population impact:

Absolute Risk Reduction (ARR): The direct difference in attack rates between the two cohorts: $$\text{ARR} = \text{AR}_u - \text{AR}_v$$
Number Needed to Vaccinate (NNV): The average number of individuals who must be immunized to prevent one additional clinical case of disease: $$\text{NNV} = \frac{1}{\text{ARR}} = \frac{100}{\text{ARR (\%) }}$$

Efficacy vs. Effectiveness: Understanding the Difference

Characteristic	Vaccine Efficacy (VE)	Vaccine Effectiveness
Study Setting	Phase III Randomized Controlled Trials (RCT)	Real-world observational cohorts and post-market surveillance
Population Cohort	Strictly selected, healthy trial participants	Heterogeneous public including elderly and immunocompromised
Logistics & Handling	Strict temperature monitoring and strict dosing intervals	Routine supply chain variations and varied real-world dosing gaps
Regulatory Benchmark	WHO / FDA standard minimum target ≥ 50%	Monitored continuously for waning immunity and variant escape

For broader epidemiological and clinical trial calculations, see our NNT Calculator and Incidence Rate Calculator.

Frequently Asked Questions

What does a 95% vaccine efficacy mean in simple terms?

A 95% vaccine efficacy means that vaccinated individuals had a 95% lower risk of developing the target disease compared to individuals in the unvaccinated placebo group. It does not mean 5% of vaccinated people get sick; rather, for every 100 cases that occur in an unvaccinated group, only 5 would occur in an equivalent vaccinated group.

What is the minimum efficacy required by regulatory bodies like the FDA and WHO?

Both the World Health Organization (WHO) and the US FDA typically mandate a minimum point estimate efficacy of at least 50% in primary Phase III clinical trial endpoints, with the lower bound of the 95% confidence interval exceeding 30%.

Why is the Number Needed to Vaccinate (NNV) dependent on disease incidence?

NNV depends inversely on the Absolute Risk Reduction (ARR). Even if a vaccine has 95% relative efficacy, if the background incidence of disease in the community is very low (e.g., 0.1%), the ARR is small, meaning more people must be vaccinated to avert a single case compared to a high-incidence epidemic setting.

Can vaccine efficacy be calculated from observational case-control studies?

Yes, in observational test-negative case-control designs, vaccine effectiveness is commonly approximated using the odds ratio ($\text{OR}$) of vaccination among cases versus controls: $\text{VE} = (1 - \text{OR}) \times 100\%$.

Report

What is Vaccine Efficacy (VE)?

Vaccine Efficacy and Relative Risk Formulas

Absolute Risk Reduction (ARR) and Number Needed to Vaccinate (NNV)

Efficacy vs. Effectiveness: Understanding the Difference

Frequently Asked Questions

Related Tools

Recent Visits